Stopping in to congratulate @shelbyK88 and Michelle Lim PA-C on @EsperionInc #ClearOutcomes Trial.
Why we #acc23. Celebrate successes for therapeutics
Stopping in to congratulate @shelbyK88 and Michelle Lim PA-C on @EsperionInc #ClearOutcomes Trial.
Why we #acc23. Celebrate successes for therapeutics
#clearoutcomes subgroups - yay benefit in women
benefit seen in 1°
as well as 2°
benefit in diabetes
Important CVOT adding #BempedoicAcid into the hall of MACE reducing #LLT.
#acc23 #HeartPA #PhysicianAssociate
#clearoutcomesN~14k, 70% 2°, 30% 1°
~22%ish
LDL-C and
hsCRP
RRR 13% 1° MACE endpt
RRR 15% 3-pt MACE
#acc23
#clearoutcomes what will we find out?up to 20% reported statin intolerance (choice not to use)
prodrug - activated in liver, low to no peripheral tissue effect (
mm aches)
4pt- 3pt- MACE
1°&2° populations
#acc23
Wow. Folks truly want to hear the #LBCT #ClearOutcomes bempedoic acid this am!!!